6505--760_Pharmaceuticals_VA CMOP Leavenworth_36C77025Q0202 760-25-2-050-0921 OM PHARM A1325, A0606 EMERGENCY (VA-25-00066272)
ID: 36C77025Q0202Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Veterans Affairs is seeking to procure pharmaceutical services through the National CMOP Contracting Office, specifically under Solicitation 36C77025Q0202. This procurement involves the awarding of contracts for pharmaceuticals, with a total of two awards made amounting to $53,856, which includes one line item awarded to JANZ Corporation and two line items awarded to Independent Pharmacy Cooperative. The awarded contracts are crucial for supporting the healthcare needs of veterans, ensuring they receive necessary medications in a timely manner. Interested vendors can reach out to Jeffrey A. Blackard at Jeffrey.Blackard@va.gov or by phone at (913) 684-0142 for further details, with responses to the solicitation due by April 16, 2025.

    Point(s) of Contact
    Jeffrey A BlackardTCF Intern
    jeffrey.blackard@va.gov
    Files
    Title
    Posted
    The document outlines a contract solicitation by the Department of Veterans Affairs, Network Contracting Office 15, for pharmaceutical supplies. Interested vendors must submit their offers by April 16, 2025. The solicitation specifies that this opportunity is unrestricted, emphasizing a preference for U.S.-made products. Vendors must provide a signed Standard Form 1449 and complete additional requirements, such as a price schedule and compliance with the Drug Supply Chain Security Act. Key points include delivery terms requiring products to be shippable by USPS, upkeep of specified therapeutic equivalence codes, and stringent requirements on barcoding and packaging. The notice also addresses invoice submission protocols, electronic payment requirements, and the consequences of failing to comply with the terms. In case of drug recalls, vendors have specific notification duties to follow. The document serves as a comprehensive guideline for vendors in regard to the conditions under which the government will procure pharmaceutical products, ensuring compliance with various regulations and emphasizing transparency and accountability in government contracting practices.
    The U.S. Department of Veterans Affairs has issued a Special Notice regarding Solicitation 36C77025Q0202, focusing on pharmaceuticals within the National CMOP Contracting Office. The contracting office is situated in Leavenworth, Kansas, with responses due by April 16, 2025. This notice does not involve Recovery Act funds and identifies the relevant product service code as 6505 and NAICS code as 325412. Two awards have been made totaling $53,856, with JANZ Corporation receiving one line item and Independent Pharmacy Cooperative receiving two line items. The point of contact for this solicitation is Jeffrey A. Blackard, reachable via email or phone. This document serves as a formal communication to inform potential vendors about the awarded contracts, their respective values, and the details surrounding the solicitation process, highlighting the government's ongoing procurement activities for pharmaceutical services.
    The Department of Veterans Affairs has issued a presolicitation notice for an emergency procurement of pharmaceuticals required at the VA CMOP facility in Leavenworth, KS. The solicitation number is 36C77025Q0202, with a response due by April 16, 2025. Contractors are expected to supply specified medications, including Amlodipine and Benazepril capsules, with delivery expected within 10 days after receipt of order (ARO). This solicitation is set aside for small businesses, and all offers must comply with the Buy American statute, requiring domestic sourcing or a separate quote for foreign products. Vendors are instructed to submit their quotes in spreadsheet format along with required documentation, including a signed solicitation cover page (SF1449), a state wholesale distributor license, and a completed Buy American certificate. The agency emphasizes the importance of monitoring the Contract Opportunities site for updates and changes. Submitted quotations must detail confirmed quantities and be sent via email to the provided point of contact. This notice is an integral part of the federal process to ensure compliance with regulatory requirements while fulfilling urgent healthcare needs for veterans.
    The document outlines the Buy American Certificate provision regarding federal procurement. It mandates that Offerors certify that their end products are domestic, unless explicitly stated otherwise. Offerors must enumerate foreign end products and specify their country of origin, along with details such as whether these products contain over 55% domestic content, except for commercially available off-the-shelf (COTS) items. The definition of critical components and other key terms are referenced from the applicable FAR regulation. The document includes sections to list both foreign end products and domestic end products containing critical components, emphasizing compliance with federal evaluation procedures in line with part 25 of the Federal Acquisition Regulation. Overall, the purpose is to ensure that government contracts promote the use of American-made products, thereby supporting domestic industry through strict adherence to procurement standards.
    The document outlines a Request for Quotation (RFQ) regarding the supply of prescription medications, specifically Amlodipine/Benzapril capsules, for the Veterans Affairs (VA) facilities. The RFQ, identified as 36C77025Q0202, is to be issued on April 9, 2025, with a submission deadline of April 16, 2025, at 9:00 AM CST. The expected awarding date is April 21, 2025, and delivery is required by May 5, 2025. Suppliers must comply with the Drug Supply Chain Security Act (DSCSA), providing state wholesale distributor licensure and other necessary compliance documents. The submission requirements include a signed solicitation cover page (SF1449), a price schedule in Excel format, and a completed Buy American certificate. The communication pertaining to submissions must occur via specified emails to several VA CMOP (Consolidated Mail Outpatient Pharmacy) departments, with clear preferences for electronic documentation formats. The emphasis is placed on meeting safety and regulatory compliance regarding the supply of medications to mitigate risks in the drug supply chain.
    Similar Opportunities
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Q517--Staffing Service Tucson
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services at its Consolidated Mail Outpatient Pharmacy (CMOP) in Tucson, Arizona, under Solicitation Number 36C77022R0008. The contract, which is a firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) agreement, requires the contractor to provide non-personal staffing for various roles, including Pharmacists, Pharmacy Technicians, and Shipper/Packer positions, ensuring a minimum staffing rate of 97% across two shifts. This procurement is critical for maintaining efficient pharmacy operations, processing over 15 million prescriptions annually, and adhering to strict compliance with VA and federal regulations, including HIPAA. Proposals are due by 10:00 AM CST on December 18, 2025, and interested parties should contact Nicholas L. Schulte at nicholas.schulte1@va.gov for further information.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Q517--FY26: VISN 8 Pharmacy Emergent First Fill Prescription Services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 8 (NCO 8), is seeking qualified contractors to provide Emergent First Fill Prescription Services for VA beneficiaries within VISN 8, which includes locations in Florida and Puerto Rico. The procurement involves a Firm Fixed Indefinite Delivery Indefinite Quantity contract, covering a base period plus four option years, to deliver 24/7 pharmaceutical benefits management services, including filling new prescriptions and adhering to a specific emergency medication formulary. This service is crucial for ensuring timely access to medications for veterans in emergency situations, with strict requirements for confidentiality and compliance. Quotes are due by December 30, 2025, at 10:00 AM EST, and interested parties should direct inquiries to Contracting Officer Colleen Houser at colleen.houser@va.gov or by phone at 727-201-6880.
    J065--Omnicell IVX Rx Framework Interface/IVX Vista Interface DSS Omnicell
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, intends to award a sole-source contract to Omnicell, Inc. for maintenance and repair services on the existing Omnicell IVX Workflow Management System at the Central Arkansas Veterans HealthCare System in Little Rock, AR. This procurement aims to secure a firm fixed price contract covering a base year plus four option years for software maintenance and support, which includes bug fixes, minor upgrades, and telephone support. The Omnicell IVX system is critical for managing workflow in healthcare settings, particularly for military veterans, and the contract is justified as Omnicell, Inc. is the only vendor capable of providing these specialized services. Interested parties may submit letters of interest demonstrating their technical expertise by December 29, 2025, to the Contracting Officer, Joseph Warren, at joseph.warren@va.gov.